| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 04/23/2008 | EP1567177B1 Mucuna pruriens and extracts thereof for the treatment of neurological diseases |
| 04/23/2008 | EP1476141B1 Tamper-resistant transdermal opioid delivery devices |
| 04/23/2008 | EP1387836B1 Phthalazine derivatives with angiogenesis inhibiting activity |
| 04/23/2008 | EP1354889B1 Transcription activation complex and utilization thereof |
| 04/23/2008 | EP1303483B1 Novel thiourea derivatives and the pharmaceutical compositions containing the same |
| 04/23/2008 | EP0998459B1 Pyridine derivatives |
| 04/23/2008 | CN101166753A Polymer conjugates of mutated neublastin |
| 04/23/2008 | CN101166742A Novel lactam compound |
| 04/23/2008 | CN101166735A Novel oxadiazole derivatives and their medical use |
| 04/23/2008 | CN101166733A Pyrazole derivatives as phosphodiesterase 4 inhibitors |
| 04/23/2008 | CN101166730A Cinnoline compounds and their use as liver X receptor modilators |
| 04/23/2008 | CN101166543A Composition containing antidementia agent |
| 04/23/2008 | CN101166536A Method for treating inflammation associated with amyloid deposits and brain inflammation involving activated microglia |
| 04/23/2008 | CN101166528A Use of a benzoyl derivative of 3-aminocarbazole for the treatment of a disorder associated with the production of prostaglandin e2 (PEG2) |
| 04/23/2008 | CN101166524A 氨基酸衍生物 Amino acid derivatives |
| 04/23/2008 | CN101165036A Ether compounds, compositions, and uses thereof |
| 04/23/2008 | CN101164619A Pyritinol injection with special purpose solvent |
| 04/23/2008 | CN101164616A Uses of anti-insulin-like growth factor 1 receptor antibodies |
| 04/23/2008 | CN101164603A Compound concentrating matrimony vine capsule and preparation method thereof |
| 04/23/2008 | CN101164571A Application of active component of cape jasmine for treating senile dementia |
| 04/23/2008 | CN101164560A Plant component aromatic preparation for relieving emotional stress, anxiety and depression and preparation method thereof |
| 04/23/2008 | CN101164536A Apigenin vesicle preparation and its preparation technology |
| 04/23/2008 | CN101164532A Duloxetine hydrochloride sustained release medicine |
| 04/23/2008 | CN100383141C Pyrazolo [4,3-d] pyrimidine derivatives |
| 04/23/2008 | CN100383126C Phenylethylamines and condensed rings variants as prodrugs of catecholamines, and their use |
| 04/23/2008 | CN100383118C 4-pyrrolidino-phenyl-benzyl ether derivatives |
| 04/23/2008 | CN100383111C Method for preparing compound of fluoro aromatic hydrocarbon |
| 04/23/2008 | CN100382808C Application of semen desc urainia oil in preparation of composition with cranial nerve regulation function |
| 04/23/2008 | CN100382802C Drug for treating function disorder of autonomic nervous system |
| 04/22/2008 | USRE40259 side effects reduction; compounds active on the central nervous system; chronic and neuropathic pain, anti-epileptic, anti-Parkinson, neuroprotective, antidepressant, antispastic and hypnotic agents; 2-[4-(3-fluorobenzyloxy)benzylamino]-2-methylpropanamide |
| 04/22/2008 | US7361787 Prophylaxis of respiratory disorders and therapy, also metod of synthesis and composition with PDE4 inhibitor, corticosteroid hibitor or anticholinergic agent |
| 04/22/2008 | US7361774 therapeutic agent or prophylactic agent for a disease requiring neuronal protection, suppression for nitrogen monoxide (NO) production, inhibition for aldose reductase or suppression for interleukin production, foodstuff or feed; 1-(5,6,7,8,8a,10a-hexahydro-1,7-dihydroxy-8,8,10a-trimethyl-9H-xanthen-4-yl |
| 04/22/2008 | US7361773 dealkylation of a benzodioxane aniline in presence of chloroethanol |
| 04/22/2008 | US7361758 crystal of a non-solvate of (3R)-1-butyl-2,5-dioxo-3-[(1R)-1-hydroxy-1-cyclohexylmethyl]-9-[4-(4-carboxyphenyloxy)phenylmethyl]-1,4,9-triazaspiro[5.5]undecane hydrochloride; chemokine antagonist |
| 04/22/2008 | US7361688 Substituted aminoalcohols useful in treatment of Alzheimer's disease |
| 04/22/2008 | US7361687 Antagonists of the B2 receptor of bradykinin; analgesics; hyperalgesia and major algesia; cancer; nontoxic; industrial scale; 5-[[(2,4-dichloro-3-methylphenyl)sulphonyl]methylamino]-N-[[4-(4,5-dihydro-1H-imidazol-2-yl)phenyl]methyl]-N-methyl-pentanamide |
| 04/22/2008 | US7361681 Method of treating amytrophic lateral sclerosis using melatonin |
| 04/22/2008 | US7361678 Azole derivatives and fused bicyclic azole derivatives as therapeutic agents |
| 04/22/2008 | US7361671 E.g.,(6-Ethyl-3-(4,5,7-trifluoro-benzothiazol-2-ylmethyl)-pyrr (2,3-b)pyridin-1-yl)acetic acid; interacts with and inhibits aldose reductase; antidiabetic agents and diabetic complications; gout; hypoglycemic and antiarthritic |
| 04/22/2008 | US7361670 Amide derivatives as NMDA receptor antagonists |
| 04/22/2008 | US7361668 Quinuclidine derivatives processes for preparing them and their uses as m2 and/or m3 muscarinic receptor inhibitors |
| 04/22/2008 | US7361666 Ligands for cellular receptors, including opiate receptors; side effect reduction; base structure is a saturated nitrogen-containing ring substituted with a tertiary amide that is N-substituted with an arylalkyl group |
| 04/22/2008 | US7361502 Nucleic acid molecule encoding a neuronal serine-threonine protein kinase |
| 04/22/2008 | US7361484 Truncated glycogen synthase kinase 3 crystallizable polypeptide; drug screening for Alzheimer's Disease treatments, antidiabetic and antiinflammatory agents; exposing a GSK3- beta molecule to a putative inhibitor, and measuring the specific enzymatic activity of said GSK3- beta molecule |
| 04/22/2008 | US7361358 Treating a non-spasm caused pain with botulinum toxin |
| 04/22/2008 | CA2400447C Kinase inhibitors |
| 04/22/2008 | CA2390685C Methods and compositions for inhibiting neoplastic cell growth |
| 04/22/2008 | CA2362697C Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-10-ols, method for producing them and their use as medicaments |
| 04/22/2008 | CA2359813C Nicotine mucosal spray |
| 04/22/2008 | CA2354619C Intermediates and process for producing fluorine-containing amino acid compound by using the same |
| 04/22/2008 | CA2350137C New piperazine and di-dehydropiperidine compounds |
| 04/22/2008 | CA2302669C Piperidinylmethyloxazolidinone derivative |
| 04/22/2008 | CA2297082C Therapeutic and dietary compositions containing essential fatty acids and bioactive disulphides |
| 04/22/2008 | CA2270777C Quinoline and quinazoline derivatives having corticotropin releasing factor (crf) antagonist activity |
| 04/22/2008 | CA2180816C 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds as pharmaceutical active ingredients |
| 04/17/2008 | WO2008046087A2 Spiro compounds and their uses as therapeutic agents |
| 04/17/2008 | WO2008046049A1 Spiro (furo [3, 2-c] pyridine-3-3 ' -indol) -2' (1'h)-one derivatives and related compounds for the treatment of sodium-channel mediated diseases, such as pain |
| 04/17/2008 | WO2008045641A2 Composition s comprising a benzodiazepine, an alcohol aversive agent and an abuse aversive agent |
| 04/17/2008 | WO2008045391A2 Novel crystal of (s)-(+)-2-(2-chlorophenyl)-2-hydroxy-ethyl carbamate |
| 04/17/2008 | WO2008045371A2 N-substituted-azacyclylamines as histamine-3 antagonists |
| 04/17/2008 | WO2008045358A1 Porphyrin catalysts and methods of use thereof |
| 04/17/2008 | WO2008045060A1 Robust sustained release formulations |
| 04/17/2008 | WO2008045047A1 Robust sustained release formulations of oxymorphone and methods of use thereof |
| 04/17/2008 | WO2008045046A1 Robust sustained release formulations of oxymorphone |
| 04/17/2008 | WO2008044928A1 Complement inhibition for improved nerve regeneration |
| 04/17/2008 | WO2008044848A1 A composition comprising an extract of rhei rhizoma or physcion compound isolated therefrom for treating or preventing cognitive dysfunction and the use thereof |
| 04/17/2008 | WO2008044785A1 Material for improvement of cerebral blood flow, and use thereof |
| 04/17/2008 | WO2008044762A1 Thioglucose spiroketal derivative and use thereof as therapeutic agent for diabetes |
| 04/17/2008 | WO2008044700A1 GSK-3β INHIBITOR |
| 04/17/2008 | WO2008044691A1 Antidepressant agent |
| 04/17/2008 | WO2008044656A1 Imidazolidinone derivative |
| 04/17/2008 | WO2008044632A1 1-naphthyl alkylpiperidine derivative |
| 04/17/2008 | WO2008044336A1 Crystal-containing adhesive preparation |
| 04/17/2008 | WO2008044054A2 Hydroxy-substituted benzoic acid amide compounds for use in therapy |
| 04/17/2008 | WO2008043839A1 Aryl piperazine derivatives useful for the treatment of neuropsychiatry disorders |
| 04/17/2008 | WO2008043800A1 Polymorph b of n-{2-fluoro-5-[3-(thiophene-2-carbonyl)-pyrazolo[1,5-a] pyrimidin-7-yl]-phenyl}-n-methyl-acetamide |
| 04/17/2008 | WO2008043775A1 Substituted pyrazinone derivatives for use as a medicine |
| 04/17/2008 | WO2008043263A1 Isoxazole derivatives and methods of treating diseases |
| 04/17/2008 | WO2008043241A1 A fusion protein carrying neurotrophin across the blood-brain barrier, encoding gene and uese thereof |
| 04/17/2008 | WO2008027395A3 Pharmaceutical compositions of benzodiazepines and methods of use thereof |
| 04/17/2008 | WO2008027357A3 Pharmaceutical compositions of clonazepam and methods of use thereof |
| 04/17/2008 | WO2008020302A3 Heteroaromatic quinoline-based compounds as phosphodiesterase (pde) inhibitors |
| 04/17/2008 | WO2008019395A9 Compounds for improving learning and memory |
| 04/17/2008 | WO2008019372A3 2-aminobenzoxazole carboxamides as 5ht3 modulators |
| 04/17/2008 | WO2008012439A3 Use of a ginkgo biloba extract for the treatment of mitochondrial diseases of genetic origin |
| 04/17/2008 | WO2008010061A3 3-azabicyclo [3.1.0] hexane vanilloid receptor ligands, pharmaceutical compositions containing them, and processes for their preparation |
| 04/17/2008 | WO2008000745A3 Adenosine derivatives for the treatment of pain |
| 04/17/2008 | WO2007147771A3 Tetralin and indane derivatives and uses thereof |
| 04/17/2008 | WO2007146085A3 Creatine phosphate prodrugs, compositions and uses thereof |
| 04/17/2008 | WO2007144083A3 Ache-nmda combination wafer |
| 04/17/2008 | WO2007137071A3 Compositions of r(+) and s(-) pramipexole and methods of using the same |
| 04/17/2008 | WO2007133749A3 Methods and compositions for treating and preventing peripheral nerve damage |
| 04/17/2008 | WO2007128924A3 Aqueous tobacco leaf extract, uses thereof in the treatment of dependence |
| 04/17/2008 | WO2007123949A3 Cannabinoid receptor modulators |
| 04/17/2008 | WO2007117440A3 Stimulation of neuron regeneration by secretory leukocyte protease inhibitor |
| 04/17/2008 | WO2007094027A3 Methods for the diagnosis of proliferative and/or conformational diseases |
| 04/17/2008 | WO2007042571A8 Novel pyrimidine-2,4-diamine derivatives and their use as modulators of small-conductance calcium-activated potassium channels |
| 04/17/2008 | US20080091020 Polymorphic forms of ziprasidone HCI and processes for their preparation |
| 04/17/2008 | US20080090913 Sphingolipid-Derived Phamaceutical Compositions |
| 04/17/2008 | US20080090908 Transformating growth factors; mucor/borage oils; multiple sclerosis |